Clinical trial Recruiting at 1 site Interventional Ages 18 and up

On-Trac: Online training to manage anxiety after cancer

Official title: Online Training After Cancer (On-Trac): Developing An Online Intervention for Cancer Survivors Managing Anxiety

Run by Dana-Farber Cancer Institute · NCT07305740 · Data updated 2026-11-12

This program will try an online CBT- and ACT-based education plus brief coaching to help adult cancer survivors manage ongoing anxiety.

More Anxiety trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorDana-Farber Cancer Institute
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedMarch 11, 2026
Main results expectedOctober 31, 2027
Study endsDecember 31, 2027
Registry record updatedMay 13, 2026
Trial IDNCT07305740 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with a non-melanoma-skin-cancer diagnosis at least 12 months earlier, no active cancer therapy in the past 4 months and none planned, clinically significant anxiety (positive SCID screener items and OASIS ≥6), regular internet access, and English literacy.

Probably not a fit

People with recent or planned active cancer treatment, prominent panic disorder or obsessive-compulsive symptoms as defined in the exclusions, limited internet access, or insufficient English reading/writing skills are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This minimal-risk behavioral optimization trial refines On-Trac, an online education program based on Cognitive-Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) for adult cancer survivors with anxiety. About 80 participants will be recruited into four age-based cohorts and will complete a 120-minute online group session, 1–2 individual coaching calls, web-based questionnaires, and telephone interviews at 4 and 8 weeks. Eligibility screening uses diagnostic screener items and an OASIS score, and all intervention and follow-up procedures are conducted via videoconference and web-survey platforms. Participants receive modest gift card incentives for completing evaluations.

Why it matters

Potential benefit: If successful, On-Trac could reduce anxiety symptoms and teach survivors practical CBT/ACT skills to manage worry and avoidance.

How similar studies have gone: Previous digital CBT and ACT programs for anxiety, including interventions for cancer survivors, have shown modest-to-moderate benefits, so this approach builds on existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18
* A diagnosis of cancer (except non-melanoma skin cancer) ≥ 12 months prior.
* No active cancer therapy (excluding chemoprevention) in the past 4 months, and no further therapy planned.
* Significant anxiety as evidenced by both of the following

  * Endorsement of the SCID ( Structured Clinical Interview for the DSM-5) Screener Items for Social Anxiety Disorder, Generalized Anxiety Disorder, Agoraphobia, Specific Phobia, or Illness Anxiety Disorder.
  * A score ≥ 6 on the Overall Anxiety Severity and Impairment Scale (OASIS).
* Regular access to the internet.
* Ability to read and write in English.

Exclusion Criteria:

* Significant symptoms of Panic Disorder in the prior month, including anticipatory anxiety of having a future panic attack or avoidance symptoms associated with panic attacks, as assessed by three SCID-5 items from the panic attack disorder module.
* Significant symptoms of Obsessive Compulsive Disorder, as evidenced by any obsessions over the past 3 months, as assessed by three SCID items from the Obsessive Compulsive Disorder module.
* Psychiatric hospitalizations or emergency room visits for psychiatric care in the prior 2 years.
* In the next two months, intention to use or likelihood of using emergent or "rescue" anxiety medication (e.g., Ativan, Xanax, Valium) or self-prescribed substances (i.e., marijuana) at the onset of anxiety symptoms or when entering a situation where they expect to experience anxiety.
* Any significant marijuana use which could impact anxiety symptoms, as evidenced by one of the following:

  * 4 days of marijuana use in any week in the last month
  * 20 milligrams of THC (Tetrahydrocannabinol) products in any week in the last month.
* Participation in any CBT or ACT-based behavioral or education intervention for anxiety in the past 2 years. This includes in-person, asynchronous, and synchronous online anxiety programs, and therapy that includes these skills. This does not include independent use of any self-help materials (i.e., workbooks, books).
* Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all parts of the study independently.

Where it's running

  • Dana Farber Cancer Institute
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Christopher J Recklitis, PhD, MPH — Dana-Farber Cancer Institute
  • Study coordinator: On-Trac Study Coordinator
  • Email: ontrac@dfci.harvard.edu
  • Phone: 617-582-8260

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.